Evaluating the effect of intranasal insulin administration on spatial memory in an animal model of Alzheimer's disease; the role of mitochondrial biogenesis

authors:

avatar Faeghe Shahrezaee , avatar Elmira Beirami , * , avatar Delaram Eslimi Esfahani

Koomesh: Vol.25, issue 3; 309-317
published online: September 02, 2023
article type: Research Article
received: February 02, 2023
accepted: June 02, 2023

how to cite: Shahrezaee F, Beirami E, Eslimi Esfahani D. Evaluating the effect of intranasal insulin administration on spatial memory in an animal model of Alzheimer's disease; the role of mitochondrial biogenesis. koomesh. 2023;25(3):e152829. 

Abstract

Introduction: Alzheimer's disease (AD) is the most common neurodegenerative disease, which is associated with progressive cognitive disorders and memory loss. Insulin has recently gained more attention for its anti-inflammatory, cognitive, and protective effects. This study aimed to investigate the effect of intranasal insulin administration on cognitive functions and mitochondrial biogenesis in rats treated with streptozotocin (STZ). Materials and Methods: In this experimental study, 32 adult male Wistar rats were used. Correspondingly, to induce an animal model of AD, STZ was injected bilaterally in the lateral ventricles (3 mg/rat; 3 μl/ventricle). Morris water maze was used to investigate cognitive disorders and confirm the induction of the AD animal model. Treatment was performed by intranasal insulin administration (2 IU/rat/day; 10 μl/nostril) after STZ injection for 14 consecutive days. Changes in the expression of genes involved in mitochondrial biogenesis (PGC-1α, NRF-1, and TFAM) were measured by Real-time PCR technique in the hippocampus. Results: The results of the study showed that STZ injection led to spatial memory disorder concomitant with a decrease in the expression of genes involved in mitochondrial biogenesis in the hippocampus of rats. Whereas, intranasal insulin administration reduced cognitive disorders and increased the expression of genes involved in mitochondrial biogenesis in the hippocampus of animals treated with STZ. Conclusion: Insulin can reduce STZ-induced cognitive disorders by affecting the mitochondrial biogenesis pathway, so it can be considered an important target for reducing cognitive deficits in AD patients.

References

  • 1.

    Calsolaro V, Femminella GD, Rogani S, Esposito S, Franchi R, Okoye C, et al. Behavioral and psychological symptoms in dementia (BPSD) and the use of antipsychotics. Pharmaceuticals (Basel) 2021; 14: 246.

  • 2.

    Javadpour P, Askari S, Rashidi FS, Dargahi L, Ahmadiani A, Ghasemi R. Imipramine alleviates memory impairment and hippocampal apoptosis in STZ-induced sporadic Alzheimer's rat model: Possible contribution of MAPKs and insulin signaling. Behav Brain Res 2021; 408: 113260.

  • 3.

    Akhtar A, Dhaliwal J, Saroj P, Uniyal A, Bishnoi M, Sah SP. Chromium picolinate attenuates cognitive defcit in ICV STZ rat paradigm of sporadic Alzheimer's like dementia via targeting neuroinfammatory and IRS 1/PI3K/AKT/GSK 3 pathway. Infammopharmacology 2020; 28: 385-400.

  • 4.

    Grieb P. Intracerebroventricular streptozotocin injections as a model of Alzheimer's disease: in search of a relevant mechanism. Mol Neurobiol 2016; 53: 1741-1752.

  • 5.

    Moosavi M, Hooshmandi E, Javadpour P, Maghsoudi N, Katinger H, Ghasemi R. Effect of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) on learning and memory impairment and hippocampal apoptosis induced by intracerebroventricular administration of streptozotocin in rats. Behav Brain Res 2020; 384: 112554.

  • 6.

    Chan DC. Fusion and fission: interlinked processes critical for mitochondrial health. Annu Rev Genet 2012; 46: 265-287.

  • 7.

    Popov LD. Mitochondrial biogenesis: An update. J Cell Mol Med 2020; 24: 4892-4899.

  • 8.

    Wang G, Song Y, Feng W, Liu L, Zhu Y, Xie X, et al. Activation of AMPK attenuates LPS-induced acute lung injury by upregulation of PGC1 and SOD1. Exp Ther Med 2016; 12: 1551-1555.

  • 9.

    Halling JF, Pilegaard H. PGC-1-mediated regulation of mitochondrial function and physiological implications. Appl Physiol Nutr Metab 2020; 45: 927-936.

  • 10.

    Singulani MP, Pereira CP, Ferreira AF, Garcia PC, Ferrari GD, Alberici LC, et al. Impairment of PGC-1-mediated mitochondrial biogenesis precedes mitochondrial dysfunction and Alzheimer's pathology in the 3xTg mouse model of Alzheimer's disease. Exp Gerontol 2020; 133: 110882.

  • 11.

    Duarte AI, Moreira PI, Oliveira CR. Insulin in central nervous system: more than just a peripheral hormone. J Aging Res 2012; 2012: 384017.

  • 12.

    Agrawal R, Reno CM, Sharma S, Christensen C, Huang Y, Fisher SJ. Insulin action in the brain regulates both central and peripheral functions. Am J Physiol Endocrinol Metab 2021; 321: 156-163.

  • 13.

    Ferreira ST. Brain insulin, insulin-like growth factor 1 and glucagon-like peptide 1 signalling in Alzheimer's disease. J Neuroendocrinol 2021; 33: e12959.

  • 14.

    Rajasekar N, Nath C, Hanif K, Shukla R. Intranasal insulin administration ameliorates streptozotocin (ICV)-induced insulin receptor dysfunction, neuroinflammation, amyloidogenesis, and memory impairment in rats. Mol Neurobiol 2017; 54: 6507-6522.

  • 15.

    Mehla J, Pahuja M, Gupta YK. Streptozotocin-induced sporadic Alzheimer's disease: selection of appropriate dose. J Alzheimers Dis 2013; 33: 17-21.

  • 16.

    Verma V, Singh D, KH R. Sinapic acid alleviates oxidative stress and neuro-inammatory changes in sporadic model of Alzheimer's disease in rats. Brain Sci 2020; 10: 923.

  • 17.

    Ronaghi A, Zibaii MI, Pandamooz S, Nourzei N, Motamedi F, Ahmadiani A, et al. Entorhinal cortex stimulation induces dentate gyrus neurogenesis through insulin receptor signaling. Brain Res Bull 2019; 144: 75-84.

  • 18.

    Rao X, Huang X, Zhou Z, Lin X. An improvement of the 2(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath 2013; 3: 71-85.##.

  • 19.

    Gizurarson S. Anatomical and histological factors affecting intranasal drug and vaccine delivery. Curr Drug Deliv 2012; 9: 566-582.

  • 20.

    Bassani TB, Bonato JM, Machado MM, Cppola-Segovia V, Moura EL, Zanata SM, et al. Decrease in adult neurogenesis and neuroinflammation are involved in spatial memory impairment in the streptozotocin-induced model of sporadic Alzheimer's disease in rats. Mol Neurobiol 2018; 55: 4280-4296.

  • 21.

    Halawany AM, Sayed NS, Abdallah HM, Dine RS. Protective effects of gingerol on streptozotocin-induced sporadic Alzheimer's disease: emphasis on inhibition of -amyloid, COX-2, alpha, beta-secretases and APH1a. Sci Rep 2017; 7: 2902.

  • 22.

    Rai S, Kamat PK, Nath C, Shukla R. Glial activation and post-synaptic neurotoxicity: the key events in Streptozotocin (ICV) induced memory impairment in rats. Pharmacol Biochem Behav 2014; 117: 104-117.

  • 23.

    Correia SC, Santos RX, Santos MS, Casadesus G, Lamanna JC, Perry G, et al. Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease. Curr Alzheimer Res 2013; 10: 406-419.

  • 24.

    Ruiz A, Alberdi E, Matute C. Mitochondrial division inhibitor 1 (mdivi-1) protects neurons against excitotoxicity through the modulation of mitochondrial function and intracellular Ca2+ signaling. Front Mol Neurosci 2018; 11: 3.

  • 25.

    Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, et al. Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia. JAMA Neurol 2020; 77: 1099-1109.

  • 26.

    Santiago JCP, Hallschmid M. Outcomes and clinical implications of intranasal insulin administration to the central nervous system. Exp Neurol 2019; 317: 180-190.

  • 27.

    Farzampour S, Majdi A, Sadigh-Eteghad S. Intranasal insulin treatment improves memory and learning in a rat amyloid-beta model of Alzheimer's disease. Physiol Int 2016; 103: 344-353.

  • 28.

    Bazrgar M, Khodabakhsh P, Dargahi L, Mohagheghi F, Ahmadiani A. MicroRNA modulation is a potential molecular mechanism for neuroprotective effects of intranasal insulin administration in amyloid eta oligomer induced Alzheimer's like rat model. Exp Gerontol 2022; 164: 111812.

  • 29.

    Brabazon F, Wilson CM, Jaiswal S, Reed J, Frey Nd WH, Byrnes KR. Intranasal insulin treatment of an experimental model of moderate traumatic brain injury. J Cereb Blood Flow Metab 2017; 37: 3203-3218.

  • 30.

    Rajasekar N, Nath C, Hanif K, Shukla R. Intranasal insulin exerts benecial effects by improving cerebral blood ow, Nrf-2 expression and BDNF in STZ (ICV) induced memory-impaired rats. Life Sci 2017; 173: 1-10.

  • 31.

    Hong CT, Chen KY, Wang W, Chiu JY, Wu D, Chao TY, et al. Insulin resistance promotes parkinson's disease through aberrant expression of -synuclein, mitochondrial dysfunction, and deregulation of the polo-like kinase 2 signaling. Cells 2020; 9: 740.

  • 32.

    Piantadosi CA, Carraway MS, Babiker A, Suliman HB. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ Res 2008; 103: 1232-1240.

  • 33.

    Beirami E, Oryan S, Tamijani SM, Ahmadiani A, Dargahi L. Intranasal insulin treatment restores cognitive deficits and insulin signaling impairment induced by repeated methamphetamine exposure. J Cell Biochem 2018; 119: 2345-2355.